ISSN: 2155-983X
+44 1300 500008
Rutledge Ellis-Behnke
Director, Nanomedicine Translational Think Tank, Department of Ophthalmology
Ruprecht-Karls-University Heidelberg, Germany
Rutledge Ellis-Behnke is Professor at the University of Heidelberg Mannheim Faculty of Medicine, where he is the Director of the Nanomedicine Translational Think Tank. In addition he is Research Affiliate in the Brain and Cognitive Sciences department at the Massachusetts Institute of Technology. Previously he was Associate Director of the Technology Transfer Office and Associate Professor in the Faculty of Medicine at the University of Hong Kong. He received his PhD from MIT in Neuroscience BSc from Rutgers University and graduated from Harvard Business School’s International Senior Manager’s Program AMP/ISMP. Prior to returning to school to pursue his PhD EllisBehnke held various management positions including Senior Vice President of Huntingdon a public company for testing and consulting services and Cofounder/CEO in 1995 of one of the first internet companies to do online commerce.
His primary research interest is using nanotechnology to reconnect the disconnected parts of the brain in order to restore function.